Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Novartis updates US label on Gilenya® following discussions with the FDA
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Lessons from Jack Griffin and the "pathogenesis of peripheral nerve disease".
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Multiple sclerosis: a primary care perspective.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
Extracranial Venous abnormalities: A true pathological finding in patients with multiple sclerosis or an anatomical variant?
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
MRI in multiple sclerosis: a review of the current literature.
Pages
« first
‹ previous
…
159
160
161
162
163
164
165
166
167
…
next ›
last »